Provided by Tiger Fintech (Singapore) Pte. Ltd.

Femasys Inc

1.50
-0.0600-3.85%
Post-market: 1.500.00000.00%17:31 EST
Volume:90.21K
Turnover:137.05K
Market Cap:34.35M
PE:-1.82
High:1.59
Open:1.57
Low:1.50
Close:1.56
Loading ...

Press Release: Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

Dow Jones
·
12 Nov 2024

BRIEF-Femasys Announces Issued U.S. Patent Covering FemBloc Device For Female Permanent Birth Control

Reuters
·
01 Nov 2024

Femasys Says It Received US Patent for Female Birth Control Device FemBloc

MT Newswires Live
·
01 Nov 2024

Femasys issued U.S. patent covering FemBloc device

TIPRANKS
·
01 Nov 2024

Femasys Announces Issued U.S. Patent Covering Fembloc® Device for Female Permanent Birth Control

THOMSON REUTERS
·
01 Nov 2024

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Oct 2024

Strategic Partnerships and Market Potential Drive Positive Outlook for FemaSeed Amidst Risks

TIPRANKS
·
31 Oct 2024

Femasys announces partnership with Boston IVF

TIPRANKS
·
30 Oct 2024

Femasys Announces Partnership With Boston IVF, Prominent Network of Fertility Centers, to Offer Femaseed

THOMSON REUTERS
·
30 Oct 2024

Femasys to exhibit at ASRM 2024, participate in KEEPR Education Program

TIPRANKS
·
10 Oct 2024

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Sep 2024

Femasys’s Strategic Expansion and Market Potential Bolster Buy Rating

TIPRANKS
·
12 Sep 2024

BRIEF-Femasys Secures Strategic Distribution Partnerships For Commercialization Of FemaSeed For Over $1.3 Mln In Spanish Market

Reuters
·
11 Sep 2024

Femasys Secures Strategic Distribution Partnerships for Commercialization of Femaseed® for Over $1.3M in Spanish Market

THOMSON REUTERS
·
11 Sep 2024

Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device

Zacks
·
10 Sep 2024

Femasys Permanent Birth Control Solution Gets 510(k) Clearance

MT Newswires Live
·
10 Sep 2024